NasdaqGS:RPRXPharmaceuticals
Does Royalty Pharma’s (RPRX) Index Upgrade Signal Deeper Defensive Strength In Its Business Model?
Royalty Pharma plc (NasdaqGS:RPRX) was recently added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, expanding its presence in widely followed US equity benchmarks.
This dual inclusion could increase Royalty Pharma’s visibility among institutional investors and index-tracking funds, potentially influencing trading volumes and portfolio positioning decisions around the stock.
With Royalty Pharma now included in key Russell 1000 defensive indices, we’ll...